Australia's largest stock trading and investment forum Australia's #1 stock forum

AKE allkem limited

0.00%

$9.83

These anecdotes about "I see EVs everywhere" say nothing about...

First 831 Last

Share
Profile

Follow
pastperformer

8,660 Posts.

2614

20/09/23

07:48

Post #: 69926466
Share

Originally posted by KTM1: ↑

Funny.... Last month I was in Delhi, India / they are adopting EV rapidly and still in its infancy....
This month I'm in France there are Teslas and other EVs everywhere .. very impressed.
Last year Eastern Europe (less so but happening).

I have owned a model Y since March $600 for 12,000 km (no expensive service required yet).

Power generation will happen modular Nuclear Thorium reactors, renewable grid batteries. This transition is in its infancy but now unstoppable- it's a great direction to be heading and will only get better.

Don't let petrochemical companies keep us with the dinosaurs.

Expand

These anecdotes about "I see EVs everywhere" say nothing about forward sales books. We all know EVs have gone through a boom. The question is about the growth of that demand going forward, because the current projections are incredibly optimistic imo.

Last edited by pastperformer: 20/09/23

AKE Price at posting: $12.43 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 831 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

These anecdotes about "I see EVs everywhere" say nothing about...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News